We envision a future where neurodegenerative diseases are detected early, allowing for timely interventions that can alter the course of the disease. In pioneering blood-based diagnostics, we aim to transform the landscape of neurological healthcare.
We apply advanced sequencing methods and proprietary algorithms to detect neuron type–specific cell-free DNA in blood plasma, pushing the boundaries of what is possible in neurodegeneration research.
We actively partner with leading institutions to rigorously validate our assays and broaden their use across both research and clinical settings, ensuring maximum scientific and medical impact.
We design minimally invasive and highly accessible diagnostic tests with a strong focus on patient comfort, ease, and overall convenience, making early detection more practical and widely available.
